This year has been unlike any other. Diagnostic providers have faced many challenges managing a rollercoaster of testing volume – with its associated claims and revenue implications – driven by COVID-19. XIFIN and its innovative laboratory solutions and services have played an important role in supporting these providers as they handle high testing volume and reimbursement challenges during the COVID-19 pandemic.
Amid these obstacles, XIFIN is thrilled to announce that our revenue cycle management (RCM) solution received the “highest client satisfaction” designation from Black Book Research again in 2020. This marks the fourth consecutive year that XIFIN technology innovations have been recognized in this manner. Black Book rankings are based on client experience scores crowdsourced from thousands of healthcare industry professionals and clinicians, including hospitals, clinics, physician practices, health plans, consumers, and more. This year’s accolade adds to XIFIN’s rankings across several categories over the past four years, recognizing its ongoing customer impact:
XIFIN is proud to provide the award-winning laboratory technology solutions that support diagnostic providers as they use the latest testing measures to help control the spread of COVID-19. The XIFIN Lab Volume Index analyzes weekly data from its networks and shows that the majority of diagnostic providers continue to see high testing volume, with some lab segments experiencing more than three times routine testing levels.
Earlier this year XIFIN also introduced new versions of two of its core diagnostic solutions:
XIFIN RPM 12 maximizes reimbursements and cash collections through many valuable, integrated capabilities, including robust workflow automation, enhanced patient and client engagement portals, and additional business intelligence solutions, including AI-enabled advanced analytics and insurance discovery.
XIFIN LIS 7 is the scalable SaaS-based laboratory information system (LIS) that offers multi-specialty workflows, including next-generation sequencing, and enables labs to perform testing in support of clinical trials through an integrated and interoperable platform. This year, XIFIN partnered with Dolbey & Company to integrate its Fusion Narrate® powered by nVoq voice recognition software to speech-enable XIFIN LIS.
For more information about our full suite of solutions, designed specifically for laboratories and diagnostic providers, please click here.